BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23651446)

  • 21. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
    Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
    J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study.
    Ani I; Finelli A; Alibhai SM; Timilshina N; Fleshner N; Abouassaly R
    BJU Int; 2013 Jun; 111(8):E300-5. PubMed ID: 23305148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
    Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
    BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of the 1997 TNM classification of renal cell carcinoma.
    Javidan J; Stricker HJ; Tamboli P; Amin MB; Peabody JO; Deshpande A; Menon M; Amin MB
    J Urol; 1999 Oct; 162(4):1277-81. PubMed ID: 10492179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
    Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
    Lughezzani G; Capitanio U; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Perrotte P; Montorsi F; Karakiewicz PI
    Cancer; 2009 Dec; 115(24):5680-7. PubMed ID: 19824083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
    Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
    Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Tian Z; Shariat SF; Widmer H; Zorn K; Menon M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2011 Dec; 60(6):1152-9. PubMed ID: 21868147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
    Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
    Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
    Zini L; Capitanio U; Perrotte P; Jeldres C; Shariat SF; Arjane P; Widmer H; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2009 Feb; 73(2):342-6. PubMed ID: 19041122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.